- ASSOCIATE PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- Obstetrics and Gynecology
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai St. Luke's and Mount Sinai West
Dr. Ascher-Walsh is the Director of the Gynecology and Urogynecology Division at the Department of Obstetrics, Gynecology and Reproductive Science. He has extensive experience in Urogynecology/Female Pelvic Medicine and Reconstructive Medicine and has specific training and proficiency in all areas of pelvic surgery including vaginal, laparoscopic and graft augmented surgical techniques.
Dr. Asher-Walsh is the director of Fellowship in Urogynecology/Female Pelvic Medicine and Reconstructive Surgery at Mount Sinai. He is a member of the Medical Advisory Board of the International Fund for Women and Development, Obstetric Fistula Repair in Niger, Africa; the Obstetric Fistula Subcommittee, International Urogynecology Association; and, is the Director of the New York Fibroid Center.
Dr. Ascher-Walsh has been named a Castle-Connolly/New York Magazine Top Doctor and a New York Times Magazine Super Doctor annually for the past several years.
His international research experience includes the completion of a randomized control trial and several projects examining minimally invasive techniques.
- Acute Cystitis
- Atrophic Vaginitis
- Cervical Conization
- Cervical Cryosurgery
- Cervical Dysplasia
- Chronic Pelvic Pain
- Dilation And Curettage
- Ectopic Pregnancy
- Endometrial Ablation
- Endometrial Biopsy
- Exploratory Laparotomy
- Incision And Drainage Of A Skin Abscess
- Interstitial Cystitis
- Ovarian Cyst
- Ovarian Cyst Removal
- Rectovaginal Fistula
- Robot-Assisted Laparoscopic Procedures
- Tubal Ligation
- Urethral Suspension
- Urinary Incontinence—Female
- Urinary Tract Infection
- Uterine Fibroids
- Uterine Prolapse
- Vaginal Prolapse
- Vaginal Tears
- Wound Dehiscence
MD, S.U.N.Y Health Science Center - College of Medicine
NY Columbia Presbyterian Med. Ctr.
NY Columbia Presbyterian Med. Ctr.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Ascher-Walsh did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.